SCHEMBL23883587

SCHEMBL23883587

CC(C)(C)c1cc(-c2ccc3c(c2)[nH]c2cc(-c4cc(C(C)(C)C)cc(C(C)(C)C)c4)ccc23)cc(C(C)(C)C)c1

nearest known ligand 0.53

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ KIF11 P52732 10/20 0.53
▸ RXRB P28702 7/20 0.44
▸ RXRA P19793 6/20 0.44
▸ RXRG P48443 3/20 0.44
▸ TNKS2 Q9H2K2 2/20 0.38
▸ TLR9 Q9NR96 1/20 0.36
▸ TLR8 Q9NR97 1/20 0.36
▸ TLR7 Q9NYK1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30129678 1.00 KIF11 (0.53) KIF11RXRBRXRARXRGTNKS2
SCHEMBL20595534 0.85 KIF11 (0.53) KIF11RXRBRXRARXRG
SCHEMBL30467085 0.85 KIF11 (0.53) KIF11RXRBRXRARXRG
SCHEMBL20825774 0.81 KIF11 (0.68) KIF11RXRBRXRA
SCHEMBL30129442 0.81 KIF11 (0.53) KIF11RXRBRXRARXRG
SCHEMBL23883570 0.81 KIF11 (0.53) KIF11RXRBRXRARXRG
SCHEMBL26089831 0.80 RXRB (0.42) KIF11RXRBRXRARXRG
SCHEMBL25883201 0.79 KIF11 (0.70) KIF11RXRBRXRATNKS2
SCHEMBL31673862 0.78 RXRB (0.45) KIF11RXRBRXRARXRGTNKS2
SCHEMBL29539315 0.77 KIF11 (0.81) KIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12319758-B2 Sterically hindered phosphino-urea supported nickel (II) or palladium (II) catalysts for the copolymerization of ethylene and polar comonomers DOW GLOBAL TECHNOLOGIES LLC (US) 2025-06-03 — — US disclosed
EP-4126991-B9 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL(II) OR PALLADIUM(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2025-02-19 — — EP disclosed
US-20250017109-A1 LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC DEVICE, AND LIGHTING DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2025-01-09 — — US disclosed
EP-4126991-B1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL(II) OR PALLADIUM(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2024-11-27 — — EP disclosed
WO-2023094936-A1 LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC INSTRUMENT, AND ILLUMINATION APPARATUS 株式会社半導体エネルギー研究所 2023-06-01 — — WO disclosed
US-20230129371-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL (II) OR PALLADIUM (II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-27 — — US disclosed
US-20230129371-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL (II) OR PALLADIUM (II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-27 — — US disclosed
US-20230129371-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL (II) OR PALLADIUM (II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2023-04-27 — — US disclosed
EP-4126991-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL(II) OR PALLADIUM(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS Dow Global Technologies LLC (US) 2023-02-08 — — EP disclosed
WO-2021202722-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL(II) OR PALLADIUM(II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2021-10-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12319758-B2 Sterically hindered phosphino-urea supported nickel (II) or palladium (II) catalysts for the copolymerization of ethylene and polar comonomers PCNA, NIT2, MCM7 KIF11 3734/4885RXRB 4848/4885RXRA 4851/4885
US-20230129371-A1 STERICALLY HINDERED PHOSPHINO-UREA SUPPORTED NICKEL (II) OR PALLADIUM (II) CATALYSTS FOR THE COPOLYMERIZATION OF ETHYLENE AND POLAR COMONOMERS PCNA, NIT2, MCM7 KIF11 3734/4885RXRB 4848/4885RXRA 4851/4885
US-20250017109-A1 LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ORGANIC COMPOUND, ELECTRONIC DEVICE, AND LIGHTING DEVICE CYBA, LEF1, OXER1 KIF11 3914/4885RXRB 2450/4885RXRA 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback